July 1, 2020 / Ameriderm Research
Ameriderm Research is nearing its final enrollment for a clinical trial is for patients aged 12 to 17 with moderate to severe atopic. The trial involves administering oral medication co-administered with topical therapy as a double-blind, randomized, placebo treatments controlled for 52 weeks with possible extension up to 136 weeks of treatment.
The trial enrollment is expected to end soon.
CALL TODAY (386) 523-0768 to see if you qualify.